Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Increased prolyl endopeptidase activity in human neoplasia.

Larrinaga G, Perez I, Blanco L, López JI, Andrés L, Etxezarraga C, Santaolalla F, Zabala A, Varona A, Irazusta J.

Regul Pept. 2010 Aug 9;163(1-3):102-6. doi: 10.1016/j.regpep.2010.03.012. Epub 2010 Apr 1.

PMID:
20362629
2.

Altered peptidase activities in thyroid neoplasia and hyperplasia.

Larrinaga G, Blanco L, Errarte P, Beitia M, Sanz B, Perez I, Irazusta A, Sánchez CE, Santaolalla F, Andrés L, López JI.

Dis Markers. 2013;35(6):825-32. doi: 10.1155/2013/970736. Epub 2013 Nov 27.

3.
4.

Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.

Larrinaga G, Perez I, Blanco L, Sanz B, Errarte P, Beitia M, Etxezarraga MC, Loizate A, Gil J, Irazusta J, López JI.

Int J Med Sci. 2014 Jan 10;11(2):199-208. doi: 10.7150/ijms.7178. eCollection 2014.

5.

Cystinyl aminopeptidase activity is decreased in renal cell carcinomas.

Larrinaga G, López JI, Casis L, Blanco L, Gil J, Agirregoitia E, Varona A.

Regul Pept. 2007 Dec 4;144(1-3):56-61. Epub 2007 Jun 21.

PMID:
17692401
6.

Increased lymphocyte ATP-ase activity in patients with carcinomas of the oral cavity and larynx.

Ellegaard J, Traunberg H, Dorff B, Esmann V.

Acta Otolaryngol. 1975 Nov-Dec;80(5-6):459-64.

PMID:
128275
7.

Overexpression of the angiogenic tetrapeptide AcSDKP in human malignant tumors.

Liu JM, Kusinski M, Ilic V, Bignon J, Hajem N, Komorowski J, Kuzdak K, Stepien H, Wdzieczak-Bakala J.

Anticancer Res. 2008 Sep-Oct;28(5A):2813-7.

8.

Inhibition of transfer ribonucleic acid methylase activity from several human tumors by nicotinamide and nicotinamide analogs.

Buch L, Streeter D, Halpern RM, Simon LN, Stout MG, Smith RA.

Biochemistry. 1972 Feb 1;11(3):393-7. No abstract available.

PMID:
4258169
9.

Plasma activity of prolyl endopeptidase in relation to psychopathology during immunotherapy with IFN-alpha in patients with renal cell carcinoma.

Van Gool AR, Verkerk R, Fekkes D, Sleijfer S, Bannink M, Kruit WH, van der Holt B, Scharpé S, Eggermont AM, Stoter G, Hengeveld MW.

J Interferon Cytokine Res. 2008 May;28(5):283-6. doi: 10.1089/jir.2007.0058.

PMID:
18547158
10.
11.

Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.

Pérez I, Varona A, Blanco L, Gil J, Santaolalla F, Zabala A, Ibarguen AM, Irazusta J, Larrinaga G.

Head Neck. 2009 Oct;31(10):1335-40. doi: 10.1002/hed.21099.

PMID:
19373777
12.
13.

The pattern of expression of Mn and Cu-Zn superoxide dismutase varies among squamous cell cancers of the lung, larynx, and oral cavity.

Piyathilake CJ, Bell WC, Oelschlager DK, Heimburger DC, Grizzle WE.

Head Neck. 2002 Sep;24(9):859-67.

PMID:
12211050
14.

Collagenase activity in epidermoid carcinoma of the oral cavity and larynx.

Abramson M, Schiling RW, Huang CC, Salome RG.

Ann Otol Rhinol Laryngol. 1975 Mar-Apr;84(2 PART 1):158-63.

PMID:
164814
15.

Expression of cancer testis antigens in head and neck squamous cell carcinomas.

Figueiredo DL, Mamede RC, Proto-Siqueira R, Neder L, Silva WA Jr, Zago MA.

Head Neck. 2006 Jul;28(7):614-9.

PMID:
16475205
16.

Changing patterns of failure of head and neck cancer.

Taneja C, Allen H, Koness RJ, Radie-Keane K, Wanebo HJ.

Arch Otolaryngol Head Neck Surg. 2002 Mar;128(3):324-7.

PMID:
11886352
17.

Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.

Atula T, Hedström J, Ristimäki A, Finne P, Leivo I, Markkanen-Leppänen M, Haglund C.

Oncol Rep. 2006 Sep;16(3):485-90.

PMID:
16865247
18.

Guanylate cyclase activity in normal and neoplastic squamous epithelia from the upper aero-digestive tract.

Rydell EL, Axelsson KL, Olofsson J, Wikberg JE.

ORL J Otorhinolaryngol Relat Spec. 1986;48(5):265-9.

PMID:
2878406
19.
20.

Aryl hydrocarbon hydroxylase induction levels in patients with malignant tumors associated with smoking.

Korsgaard R, Trell E, Simonsson BG, Stiksa G, Janzon L, Hood B, Oldbring J.

J Cancer Res Clin Oncol. 1984;108(3):286-9.

PMID:
6511802
Items per page

Supplemental Content

Write to the Help Desk